Skip to content

Clinical trials

Terminated Genetic Diseases, Inborn trials in France

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Genetic Diseases, Inborn Status: Terminated Country / region: France Clear all

10 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20061
20112
20141
20151
20161
20191
20213

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Terminated10

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Novartis Pharmaceuticals2
Centre Hospitalier Universitaire, Amiens1
Intergroupe Francophone du Myelome1
Kyntra Bio1
Laboratoires Thea1
ModernaTX, Inc.1
PTC Therapeutics1
Shire1
University Hospital, Strasbourg, France1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Genetic Diseases, Inborn10
Nervous System Diseases3
Fragile X Syndrome2
Genetic Diseases, X-Linked2
Metabolism, Inborn Errors2
Muscular Diseases2
Muscular Disorders, Atrophic2
Muscular Dystrophies2
Muscular Dystrophy, Duchenne2
Musculoskeletal Diseases2

Trials

Showing 1 to 10 of 10. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.